LIGAND PHARMACEUTICALS INC — Director's Dealing 2012

Sep 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2012-09-07

Reporting Person: Berkman Charles S (VP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-09-07	Common Stock	S	4249.0	$18.77	Disposed	14329.0	Direct

Footnotes

F1: The Price listed is the average price per share within a sell range of $18.75-$18.81. Upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.